AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

LGND · NASDAQ · Biotechnology

Ligand Pharmaceuticals (LGND)

Builds biopharmaceutical royalty portfolios and licenses Captisol and NITRICIL drug technologies.

$297.85

vs last close−0.65 (−0.22%)

Ligand Acquires Royalty and Milestone Interest in Santen's Ryjunea® from Sydnexis for $23 Million
GlobeNewsWireSep 22
Ligand Pharmaceuticals: Owning It Gives You A Stake Across Biotech
Seeking AlphaSep 18
Handelsbanken Fonder AB Raises Stake in Ligand Pharmaceuticals Incorporated $LGND
Defense WorldAug 16
Ligand Pharmaceuticals Q2 Earnings Call Highlights
MarketBeatAug 6
Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript
Seeking AlphaAug 6
Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Arrowstreet Capital Limited Partnership
Defense WorldAug 5
Ashford Capital Management Inc. Has $41.44 Million Holdings in Ligand Pharmaceuticals Incorporated $LGND
Defense WorldJul 28
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
GlobeNewsWireJul 23
Ligand Announces Closing of Convertible Senior Notes Offering
GlobeNewsWireJun 25
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering
GlobeNewsWireJun 23
Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031
GlobeNewsWireJun 22
Ligand Pharmaceuticals Director Unloads 2,501 Shares — Should You Be Concerned?
The Motley FoolJun 14
A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million
The Motley FoolJun 7
Ligand to Participate in June Investor Conferences
GlobeNewsWireMay 27
Ligand Pharmaceuticals Q1 Earnings Call Highlights
MarketBeatMay 8
Ligand Reports First Quarter 2026 Financial Results
GlobeNewsWireMay 7
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
GlobeNewsWireMay 6
Ligand to Participate in May Investor Conferences
GlobeNewsWireMay 5
Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook
Defense WorldApr 29
Ligand Pharmaceuticals Incorporated (LGND) M&A Call Transcript
Seeking AlphaApr 27
Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million
WSJApr 27
B. Metzler seel. Sohn & Co. AG Invests $1.30 Million in Ligand Pharmaceuticals Incorporated $LGND
Defense WorldApr 27
Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
GlobeNewsWireApr 22
Coave Therapeutics to present two posters at ARVO 2026, on first-in-class ligand-conjugated suprachoroidal vector and lead gene therapy program
GlobeNewsWireApr 22